Provided By PR Newswire
Last update: May 15, 2024
SAN DIEGO, May 15, 2024 /PRNewswire/ -- The company behind the hormone-free contraceptive Phexxi® (lactic acid, citric acid and potassium bitartrate), Evofem Biosciences, Inc. ("Evofem" or "the Company") (OTCQB: EVFM) today announced financial results for the first quarter of 2024. Highlights of and since the quarter include:
Read more at prnewswire.comNASDAQ:ADTX (7/24/2025, 1:21:20 PM)
1.25
+0.02 (+1.63%)
Find more stocks in the Stock Screener